ofloxacin has been researched along with Sensitivity and Specificity in 98 studies
Ofloxacin: A synthetic fluoroquinolone antibacterial agent that inhibits the supercoiling activity of bacterial DNA GYRASE, halting DNA REPLICATION.
9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid : An oxazinoquinoline that is 2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinolin-7-one substituted by methyl, carboxy, fluoro, and 4-methylpiperazin-1-yl groups at positions 3, 6, 9, and 10, respectively.
ofloxacin : A racemate comprising equimolar amounts of levofloxacin and dextrofloxacin. It is a synthetic fluoroquinolone antibacterial agent which inhibits the supercoiling activity of bacterial DNA gyrase, halting DNA replication.
Sensitivity and Specificity: Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate performance of thin layer agar (TLA) 7H11 method for detection of ofloxacin (OFX) and kanamycin (KM) resistance in smear positive clinical specimens of patients with tuberculosis comparing the results with gold standard MGIT 960 system." | 3.91 | Evaluation of Thin Layer Agar 7H11 for Direct Susceptibility Testing of Mycobacterium Tuberculosis Complex against Second Line Anti Tuberculosis Drugs on Smear Positive Specimens. ( Gardezi, AH; Hussain, A; Ikram, A; Khadim, MT; Satti, L; Zaman, G, 2019) |
| " leprae to dapsone based on the folP1 drug resistance determining region (DRDR), rifampin (rpoB DRDR) and ofloxacin (gyrA DRDR) was evaluated using 211 clinical specimens from leprosy patients, including 156 multibacillary (MB) and 55 paucibacillary (PB) cases." | 3.85 | qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients. ( Araujo, S; Fontes, AB; Goulart, IMB; Goulart, LR; Li, W; Matsuoka, M; Rosa, PS; Scollard, DM; Suffys, P; Truman, RW; Vissa, V; Williams, DL, 2017) |
| "Comparative susceptibility of microflora isolates from patients with complicated urinary tract infections to cefepime, other cephalosporins, amikacin, ciprofloxacin and ofloxacin was studied." | 3.72 | [Cefepime (maxipime) in the treatment of severe urinary tract infection]. ( Derevianko, II, 2003) |
| "We designed a 4-way crossover, ex-vivo pharmacodynamic study to compare the bactericidal rate of amoxicillin/sulbactam (AMX-SUL), azithromycin (AZM), doxycycline (DOX) and levofloxacin (LVX) against Streptococcus pneumoniae ATCC 49619." | 2.71 | An ex-vivo pharmacodynamic study comparing bactericidal activity of amoxicillin/sulbactam, azithromycin, doxycycline and levofloxacin against Streptococcus pneumoniae. ( Arenoso, H; Bantar, C; Caruso, N; Fernández Canigia, L; Nicola, F; Soutric, J, 2004) |
| "The difference in PSA change between prostate cancer and non-cancer patients was not statistically significant (p = 0." | 1.37 | Antimicrobial therapy for asymptomatic patients with elevated prostate-specific antigen: can the change in prostate-specific antigen reliably guide prostate biopsy decisions? ( Abdelhamid, M; Emran, A; Kamal, A; Mosharafa, A; Torky, M, 2011) |
| " The single method thus developed is applied for the quantification of levofloxacin both in aqueous humour as well as pharmaceutical dosage forms (i." | 1.36 | A single reversed-phase UPLC method for quantification of levofloxacin in aqueous humour and pharmaceutical dosage forms. ( Ali, A; Aqil, M; Chander, P; Gupta, H; Khar, RK, 2010) |
| " The developed assay method was applied to a pharmacokinetic study in human volunteers following oral administration of 400 mg GFC tablet." | 1.35 | Development and validation of a HPLC method for simultaneous quantitation of gatifloxacin, sparfloxacin and moxifloxacin using levofloxacin as internal standard in human plasma: application to a clinical pharmacokinetic study. ( Mullangi, R; Narasu, L; Shankar, BP; Srinivas, N, 2008) |
| "A simple, rapid, and accurate high-performance thin-layer chromatography (HPTLC) method is described for the simultaneous determination of levofloxacin hemihydrate and ornidazole in tablet dosage form." | 1.34 | Validated HPTLC method for simultaneous estimation of levofloxacin hemihydrate and ornidazole in pharmaceutical dosage form. ( Bari, SB; Chepurwar, SB; Fursule, RA; Shirkhedkar, AA; Surana, SJ, 2007) |
| " CAZ combined with LVX or AMK yielded Fls indicating synergism (Fl < or = 0." | 1.33 | In vitro and in vivo synergy of levofloxacin or amikacin both in combination with ceftazidime against clinical isolates of Pseudomonas aeruginosa. ( Felici, A; Guerrini, M; Marchetti, F; Piccoli, L, 2005) |
| " This study evaluated the in vitro activity of two concentrations of levofloxacin (modeled for the 500 mg and 750 mg daily dose) in combination with ceftazidime, cefepime, piperacillin/tazobactam, imipenem, and tobramycin against P." | 1.32 | In vitro evaluation of the activity of two doses of Levofloxacin alone and in combination with other agents against Pseudomonas aeruginosa. ( Burgess, DS; Hall, RG; Hardin, TC, 2003) |
| "Levofloxacin resistance was rarely associated with MDR phenotypes." | 1.32 | The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002. ( Blosser-Middleton, RS; Jones, ME; Karlowsky, JA; Sahm, DF; Thornsberry, C, 2003) |
| " Considering the major pharmacodynamic determinants for the concentration-dependent bactericidal activity of levofloxacin as applicable at the urinary level (CU/MIC of >12." | 1.32 | Urinary pharmacokinetics and theoretical pharmacodynamics of intravenous levofloxacin in intensive care unit patients treated with 500 mg b.i.d. for ventilator-associated pneumonia. ( Baldassarre, M; Brollo, L; Di Qual, E; Furlanut, M; Nascimben, E; Pavan, F; Pea, F, 2003) |
| "The aim of this study was to develop a rapid and sensitive method for the simultaneous determination of unbound levofloxacin in rat blood and bile using high-performance liquid chromatography coupled with microdialysis for further pharmacokinetic study." | 1.31 | Pharmacokinetic study of levofloxacin in rat blood and bile by microdialysis and high-performance liquid chromatography. ( Chen, YF; Cheng, FC; Hung, LC; Tsai, TH; Tsai, TR, 2002) |
| "Levofloxacin was dosed at 0 and 24 h, elimination pharmacokinetics were simulated, and viable counts were measured over 30 h." | 1.31 | Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae. ( Lister, PD, 2002) |
| "Garenoxacin was the most active agent overall against Gram-positive organisms, with potent activity against Aerococcus spp." | 1.31 | Antimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patients. ( Frisbee-Hume, S; Ho, DH; LeBlanc, BM; Rolston, KV; Streeter, H, 2002) |
| "Ciprofloxacin was used as the internal standard." | 1.30 | Rapid stereospecific high-performance liquid chromatographic determination of levofloxacin in human plasma and urine. ( Flor, SC; Juzwin, SJ; Wong, FA, 1997) |
| " This method was applied to the pharmacokinetic study of ofloxacin in 24 chronic obstructive pulmonary disease patients." | 1.29 | A reproducible, simple and sensitive HPLC assay for determination of ofloxacin in plasma and lung tissue. Application in pharmacokinetic studies. ( Bouvet, O; Bressolle, F; Fabre, D; Galtier, M; Kinowski, JM; Paganin, F, 1994) |
| " Juvenile (4- to 5-week-old) NZW were orally dosed with ofloxacin or pefloxacin (300 mg/kg of body weight for 1 day) or with pefloxacin (300 mg/kg for 7 days)." | 1.29 | Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial agents. ( Gaudin, C; Hayem, G; Kahn, MF; Levacher, M; Petit, PX; Pocidalo, JJ, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 11 (11.22) | 18.2507 |
| 2000's | 59 (60.20) | 29.6817 |
| 2010's | 27 (27.55) | 24.3611 |
| 2020's | 1 (1.02) | 2.80 |
| Authors | Studies |
|---|---|
| Diamandis, P | 1 |
| Wildenhain, J | 1 |
| Clarke, ID | 1 |
| Sacher, AG | 1 |
| Graham, J | 1 |
| Bellows, DS | 1 |
| Ling, EK | 1 |
| Ward, RJ | 1 |
| Jamieson, LG | 1 |
| Tyers, M | 1 |
| Dirks, PB | 1 |
| Rahman, SMM | 1 |
| Nasrin, R | 1 |
| Rahman, A | 1 |
| Ahmed, S | 1 |
| Khatun, R | 1 |
| Uddin, MKM | 1 |
| Rahman, MM | 1 |
| Banu, S | 1 |
| Araujo, S | 1 |
| Goulart, LR | 1 |
| Truman, RW | 1 |
| Goulart, IMB | 1 |
| Vissa, V | 1 |
| Li, W | 1 |
| Matsuoka, M | 1 |
| Suffys, P | 1 |
| Fontes, AB | 1 |
| Rosa, PS | 1 |
| Scollard, DM | 1 |
| Williams, DL | 1 |
| Javaid, A | 1 |
| Ahmad, N | 1 |
| Afridi, AK | 1 |
| Basit, A | 1 |
| Khan, AH | 1 |
| Ahmad, I | 1 |
| Atif, M | 1 |
| Hussain, A | 1 |
| Zaman, G | 1 |
| Satti, L | 1 |
| Ikram, A | 1 |
| Gardezi, AH | 1 |
| Khadim, MT | 1 |
| Yan, Z | 1 |
| Yi, H | 1 |
| Wang, L | 2 |
| Zhou, X | 1 |
| Yan, R | 1 |
| Zhang, D | 1 |
| Wang, S | 2 |
| Su, L | 1 |
| Zhou, S | 1 |
| Şimşek, H | 1 |
| Tarhan, G | 1 |
| Cesur, S | 1 |
| Ardizzoni, E | 1 |
| Mulders, W | 1 |
| Kotrikadze, T | 1 |
| Aspindzelashvili, R | 1 |
| Goginashvili, L | 1 |
| Pangtey, H | 1 |
| Varaine, F | 2 |
| Bastard, M | 1 |
| Rigouts, L | 1 |
| de Jong, BC | 1 |
| Huang, ZK | 1 |
| Luo, Q | 1 |
| Qing, C | 1 |
| Deng, YT | 1 |
| Xiong, GL | 1 |
| Li, JM | 1 |
| Pang, Y | 1 |
| Dong, H | 1 |
| Tan, Y | 1 |
| Deng, Y | 1 |
| Cai, X | 1 |
| Jing, H | 1 |
| Xia, H | 1 |
| Li, Q | 1 |
| Ou, X | 1 |
| Su, B | 1 |
| Li, X | 1 |
| Zhang, Z | 2 |
| Li, J | 2 |
| Zhang, J | 2 |
| Huan, S | 1 |
| Zhao, Y | 1 |
| Ma, Y | 1 |
| Wang, Q | 2 |
| Zhang, H | 1 |
| Xie, L | 1 |
| Chen, J | 1 |
| Huang, M | 1 |
| Liu, Y | 1 |
| Wang, Y | 1 |
| Sun, L | 1 |
| Ou, N | 1 |
| Sun, Y | 1 |
| Xi, Z | 1 |
| Srinivas, N | 1 |
| Narasu, L | 1 |
| Shankar, BP | 1 |
| Mullangi, R | 1 |
| Zorita, S | 1 |
| Larsson, L | 1 |
| Mathiasson, L | 1 |
| Sun, HW | 1 |
| Qiao, FX | 1 |
| Liu, YM | 1 |
| Jia, YX | 1 |
| Tian, W | 1 |
| He, B | 1 |
| Liao, L | 1 |
| Xiao, X | 1 |
| Gao, S | 1 |
| Wu, Y | 1 |
| Ulu, ST | 1 |
| Shirkhedkar, AA | 2 |
| Surana, SJ | 2 |
| Lin, SY | 1 |
| Desmond, E | 1 |
| Bonato, D | 1 |
| Gross, W | 1 |
| Siddiqi, S | 1 |
| Cambau, E | 1 |
| Allerheiligen, V | 1 |
| Coulon, C | 1 |
| Corbel, C | 1 |
| Lascols, C | 1 |
| Deforges, L | 1 |
| Soussy, CJ | 1 |
| Delchier, JC | 1 |
| Megraud, F | 1 |
| Martin, A | 2 |
| Paasch, F | 1 |
| Von Groll, A | 1 |
| Fissette, K | 2 |
| Almeida, P | 1 |
| Portaels, F | 1 |
| Palomino, JC | 2 |
| Watabe, S | 1 |
| Yokoyama, Y | 1 |
| Nakazawa, K | 1 |
| Shinozaki, K | 1 |
| Hiraoka, R | 1 |
| Takeshita, K | 1 |
| Suzuki, Y | 2 |
| Chang, KC | 1 |
| Yew, WW | 2 |
| Chan, RC | 1 |
| Sousa, J | 1 |
| Alves, G | 1 |
| Fortuna, A | 1 |
| Pena, A | 1 |
| Lino, C | 1 |
| Falcão, A | 1 |
| Fang, PF | 1 |
| Cai, HL | 1 |
| Li, HD | 1 |
| Zhu, RH | 1 |
| Tan, QY | 1 |
| Gao, W | 1 |
| Xu, P | 1 |
| Liu, YP | 1 |
| Zhang, WY | 1 |
| Chen, YC | 1 |
| Zhang, F | 1 |
| Aranda, A | 1 |
| Mayorga, C | 1 |
| Ariza, A | 1 |
| Doña, I | 1 |
| Rosado, A | 1 |
| Blanca-Lopez, N | 1 |
| Andreu, I | 1 |
| Torres, MJ | 1 |
| Qu, P | 1 |
| Lei, J | 1 |
| Zhang, L | 1 |
| Ouyang, R | 1 |
| Ju, H | 1 |
| Gupta, H | 1 |
| Aqil, M | 1 |
| Khar, RK | 1 |
| Ali, A | 1 |
| Chander, P | 1 |
| Chen, X | 2 |
| Kong, F | 1 |
| Li, C | 1 |
| Gilbert, GL | 1 |
| Torky, M | 1 |
| Mosharafa, A | 1 |
| Emran, A | 1 |
| Kamal, A | 1 |
| Abdelhamid, M | 1 |
| Attia, MS | 1 |
| Essawy, AA | 1 |
| Youssef, AO | 1 |
| Mostafa, MS | 1 |
| Meredith, SA | 1 |
| Smith, PJ | 1 |
| Norman, J | 1 |
| Wiesner, L | 1 |
| Said, HM | 1 |
| Kock, MM | 1 |
| Ismail, NA | 1 |
| Baba, K | 1 |
| Omar, SV | 1 |
| Osman, AG | 1 |
| Hoosen, AA | 1 |
| Ehlers, MM | 1 |
| Ramos, E | 1 |
| de Rijk, P | 1 |
| Salem, AA | 2 |
| Mossa, HA | 2 |
| Byrro, RM | 1 |
| de Oliveira Fulgêncio, G | 1 |
| da Silva Cunha, A | 1 |
| César, IC | 1 |
| Chellini, PR | 1 |
| Pianetti, GA | 1 |
| Barnard, M | 1 |
| Warren, R | 1 |
| Gey Van Pittius, N | 1 |
| van Helden, P | 1 |
| Bosman, M | 1 |
| Streicher, E | 1 |
| Coetzee, G | 1 |
| O'Brien, R | 1 |
| Sun, H | 2 |
| Wang, H | 1 |
| Ge, X | 1 |
| Jin, J | 1 |
| Shen, Y | 1 |
| Fan, X | 1 |
| Diao, N | 1 |
| Wang, F | 1 |
| Weng, X | 1 |
| Zhang, W | 1 |
| Cheng, FC | 1 |
| Tsai, TR | 1 |
| Chen, YF | 1 |
| Hung, LC | 1 |
| Tsai, TH | 1 |
| Burgess, DS | 2 |
| Nathisuwan, S | 1 |
| Lister, PD | 1 |
| Ali, MS | 1 |
| Ghori, M | 1 |
| Saeed, A | 1 |
| Rolston, KV | 1 |
| Frisbee-Hume, S | 1 |
| LeBlanc, BM | 1 |
| Streeter, H | 1 |
| Ho, DH | 1 |
| Doğan, HS | 1 |
| Sahin, A | 1 |
| Cetinkaya, Y | 1 |
| Akdoğan, B | 1 |
| Ozden, E | 1 |
| Kendi, S | 1 |
| Hall, RG | 1 |
| Hardin, TC | 1 |
| Horii, T | 1 |
| Monji, A | 1 |
| Morita, M | 1 |
| Muramatsu, H | 1 |
| Kondo, Y | 1 |
| Doi, M | 1 |
| Takeshita, A | 1 |
| Kanno, T | 1 |
| Maekawa, M | 1 |
| Cottagnoud, P | 1 |
| Cottagnoud, M | 1 |
| Acosta, F | 1 |
| Flatz, L | 1 |
| Kühn, F | 1 |
| Stucki, A | 1 |
| Entenza, J | 1 |
| Derevianko, II | 1 |
| Djabarouti, S | 1 |
| Boselli, E | 1 |
| Allaouchiche, B | 1 |
| Ba, B | 1 |
| Nguyen, AT | 1 |
| Gordien, JB | 1 |
| Bernadou, JM | 1 |
| Saux, MC | 1 |
| Breilh, D | 1 |
| Jones, ME | 1 |
| Blosser-Middleton, RS | 1 |
| Thornsberry, C | 1 |
| Karlowsky, JA | 1 |
| Sahm, DF | 1 |
| Garrison, MW | 1 |
| Schimmels, JA | 1 |
| Madaras-Kelly, KJ | 1 |
| Pea, F | 1 |
| Pavan, F | 1 |
| Di Qual, E | 1 |
| Brollo, L | 1 |
| Nascimben, E | 1 |
| Baldassarre, M | 1 |
| Furlanut, M | 1 |
| Schito, AM | 1 |
| Schito, GC | 1 |
| Viale, P | 1 |
| Scudeller, L | 1 |
| Cristini, F | 1 |
| Bantar, C | 1 |
| Nicola, F | 1 |
| Arenoso, H | 1 |
| Soutric, J | 1 |
| Caruso, N | 1 |
| Fernández Canigia, L | 1 |
| Fajardo, TT | 1 |
| Villahermosa, LG | 1 |
| Cruz, EC | 1 |
| Cellona, RV | 1 |
| Balagon, MV | 1 |
| Abalos, RM | 1 |
| Gelber, RH | 1 |
| Drago, L | 1 |
| De Vecchi, E | 1 |
| Nicola, L | 1 |
| Legnani, D | 1 |
| Prenna, M | 1 |
| Ripa, S | 1 |
| Sulochana, S | 1 |
| Rahman, F | 1 |
| Paramasivan, CN | 1 |
| Ambrosi, A | 1 |
| Antiochia, R | 1 |
| Campanella, L | 1 |
| Dragone, R | 1 |
| Lavagnini, I | 1 |
| Soledad García, M | 1 |
| Isabel Albero, M | 1 |
| Sánchez-Pedreño, C | 1 |
| Salem Abuherba, M | 1 |
| Espinosa-Mansilla, A | 2 |
| Peña, AM | 1 |
| Gómez, DG | 1 |
| Salinas, F | 1 |
| Santoro, MI | 1 |
| Kassab, NM | 1 |
| Singh, AK | 1 |
| Kedor-Hackmam, ER | 1 |
| Piccoli, L | 1 |
| Guerrini, M | 1 |
| Felici, A | 1 |
| Marchetti, F | 1 |
| Barsoum, BN | 1 |
| Muñoz de la Peña, A | 1 |
| Cañada-Cañada, F | 1 |
| González Gómez, D | 1 |
| Serra, AL | 1 |
| Klein, M | 1 |
| Nitsch, D | 1 |
| Dürr, D | 1 |
| Wermuth, B | 1 |
| Frey, FJ | 1 |
| Zivanovic, Lj | 1 |
| Zigic, G | 1 |
| Zecevic, M | 1 |
| Schulte, S | 1 |
| Ackermann, T | 1 |
| Bertram, N | 1 |
| Sauerbruch, T | 1 |
| Paar, WD | 1 |
| Li, L | 1 |
| Peng, X | 1 |
| Wang, Z | 2 |
| Kuang, W | 1 |
| Tan, J | 1 |
| Li, K | 1 |
| Yan, H | 1 |
| Row, KH | 1 |
| Zhu, Y | 1 |
| Ding, S | 1 |
| He, F | 1 |
| Beier, RC | 1 |
| Jiang, H | 1 |
| Feng, C | 1 |
| Wan, Y | 1 |
| Zhang, S | 1 |
| Kai, Z | 1 |
| Yang, X | 1 |
| Shen, J | 1 |
| Zhou, ZL | 1 |
| Yang, M | 1 |
| Yu, XY | 1 |
| Peng, HY | 1 |
| Shan, ZX | 1 |
| Chen, SZ | 1 |
| Lin, QX | 1 |
| Liu, XY | 1 |
| Chen, TF | 1 |
| Zhou, SF | 1 |
| Lin, SG | 1 |
| Lecordier, J | 1 |
| Lahet, JJ | 1 |
| Courderot-Masuyer, C | 1 |
| Beaudoin, E | 1 |
| Chaillot, B | 1 |
| Chepurwar, SB | 1 |
| Bari, SB | 1 |
| Fursule, RA | 1 |
| Bao, D | 1 |
| Truong, TT | 1 |
| Renick, PJ | 1 |
| Pulse, ME | 1 |
| Weiss, WJ | 1 |
| Cheng, GW | 1 |
| Wu, HL | 1 |
| Huang, YL | 1 |
| Fabre, D | 1 |
| Bressolle, F | 1 |
| Kinowski, JM | 1 |
| Bouvet, O | 1 |
| Paganin, F | 1 |
| Galtier, M | 1 |
| Hayem, G | 1 |
| Petit, PX | 1 |
| Levacher, M | 1 |
| Gaudin, C | 1 |
| Kahn, MF | 1 |
| Pocidalo, JJ | 1 |
| Macek, J | 1 |
| Ptácek, P | 1 |
| Doern, GV | 1 |
| Torres, BB | 1 |
| Jankins, M | 1 |
| Jones, RN | 1 |
| Basci, NE | 1 |
| Hanioglu-Kargi, S | 1 |
| Soysal, H | 1 |
| Bozkurt, A | 1 |
| Kayaalp, SO | 1 |
| Wong, FA | 1 |
| Juzwin, SJ | 1 |
| Flor, SC | 1 |
| Visalli, MA | 1 |
| Jacobs, MR | 1 |
| Appelbaum, PC | 1 |
| Jakubicz, P | 1 |
| Leszczyńska, K | 1 |
| Zhang, SS | 1 |
| Liu, HX | 1 |
| Yuan, ZB | 1 |
| Yu, CL | 1 |
| Zeng, S | 1 |
| Zhong, J | 1 |
| Pan, L | 1 |
| Li, Y | 1 |
| Hooper, DC | 1 |
| Singh, HB | 1 |
| Katoch, K | 1 |
| Natrajan, M | 1 |
| Sharma, RK | 1 |
| Gupta, UD | 1 |
| Sharma, VD | 1 |
| Singh, D | 1 |
| Chauhan, DS | 1 |
| Srivastava, K | 1 |
| Katoch, VM | 1 |
| Horstkötter, C | 1 |
| Blaschke, G | 1 |
| Karazanashvili, G | 1 |
| Managadze, L | 1 |
| Presterl, E | 1 |
| Mueller-Uri, P | 1 |
| Grisold, A | 1 |
| Georgopoulos, A | 1 |
| Graninger, W | 1 |
| Pracharktam, R | 1 |
| Angkananukool, K | 1 |
| Vibhagool, A | 1 |
| Ryan, BM | 1 |
| Mazzucco, CE | 1 |
| Lawrence, LE | 1 |
| Ho, H | 1 |
| Warr, G | 1 |
| Barrett, JF | 1 |
| Frosco, M | 1 |
| Chau, CH | 1 |
| Liang, H | 1 |
| Kays, MB | 1 |
| Sowinski, KM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Neutrophil and Lymphocyte Counts and the Neutrophil-to-lymphocyte Ratio as a Predictor of Fever Following Percutaneous Nephrolithotomy in Patients Without Risk Factors[NCT03774940] | 519 participants (Actual) | Interventional | 2005-01-01 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for ofloxacin and Sensitivity and Specificity
| Article | Year |
|---|---|
Rapid assays for fluoroquinolone resistance in Mycobacterium tuberculosis: a systematic review and meta-analysis.
Topics: Antitubercular Agents; Aza Compounds; Bacterial Proteins; DNA Gyrase; DNA, Bacterial; Drug Resistanc | 2010 |
Levofloxacin, a broad spectrum anti-infective: from Streptococcus pneumoniae to Pseudomonas aeruginosa.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Humans; Italy; Levofloxacin; Micro | 2004 |
New uses for new and old quinolones and the challenge of resistance.
Topics: Anti-Infective Agents; Bacterial Infections; Drug Resistance, Microbial; Fluoroquinolones; Humans; M | 2000 |
5 trials available for ofloxacin and Sensitivity and Specificity
| Article | Year |
|---|---|
Simultaneous quantification of antofloxacin and its major metabolite in human urine by HPLC-MS/MS, and its application to a pharmacokinetic study.
Topics: Adolescent; Adult; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Linear Mode | 2017 |
In vitro evaluation of IgE-mediated hypersensitivity reactions to quinolones.
Topics: Adolescent; Adult; Aged; Anti-Infective Agents; Aza Compounds; Basophil Degranulation Test; Ciproflo | 2011 |
Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients.
Topics: Adult; Antibiotic Prophylaxis; Bacteriuria; Dose-Response Relationship, Drug; Drug Administration Sc | 2002 |
An ex-vivo pharmacodynamic study comparing bactericidal activity of amoxicillin/sulbactam, azithromycin, doxycycline and levofloxacin against Streptococcus pneumoniae.
Topics: Adult; Amoxicillin; Analysis of Variance; Azithromycin; Blood Bactericidal Activity; Colony Count, M | 2004 |
A clinical trial of pefloxacin and ofloxacin in lepromatous leprosy.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Follow-Up Studies; Humans; L | 2004 |
90 other studies available for ofloxacin and Sensitivity and Specificity
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutic | 2007 |
Performance of GenoType MTBDRsl assay for detection of second-line drugs and ethambutol resistance directly from sputum specimens of MDR-TB patients in Bangladesh.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Bangladesh; DNA, Bacterial; Ethambutol; Exten | 2021 |
qPCR-High resolution melt analysis for drug susceptibility testing of Mycobacterium leprae directly from clinical specimens of leprosy patients.
Topics: Bacterial Proteins; Dapsone; DNA, Bacterial; Drug Resistance, Bacterial; Humans; Leprostatic Agents; | 2017 |
Validity of Time to Sputum Culture Conversion to Predict Cure in Patients with Multidrug-Resistant Tuberculosis: A Retrospective Single-Center Study.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Child; Cohort Studies; Drug Resistance, Bacterial; Female; | 2018 |
Evaluation of Thin Layer Agar 7H11 for Direct Susceptibility Testing of Mycobacterium Tuberculosis Complex against Second Line Anti Tuberculosis Drugs on Smear Positive Specimens.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitubercular Agents; Bacteriolo | 2019 |
Fluorescent aptasensor for ofloxacin detection based on the aggregation of gold nanoparticles and its effect on quenching the fluorescence of Rhodamine B.
Topics: Animals; Aptamers, Nucleotide; Dynamic Light Scattering; Fluorescent Dyes; Food Analysis; Food Conta | 2019 |
[Evaluation of second-line antituberculosis drug susceptibilities of multidrug-resistant Mycobacterium tuberculosis complex isolates by E-test method].
Topics: Acetamides; Antitubercular Agents; Culture Media; Drug Resistance, Multiple, Bacterial; Ethionamide; | 2015 |
The thin-layer agar method for direct phenotypic detection of multi- and extensively drug-resistant tuberculosis.
Topics: Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Humans; Isoniazid; Ka | 2015 |
Evaluation of the direct nitrate reductase assay for rapid detection of extensively drug-resistant tuberculosis.
Topics: Adult; Capreomycin; China; Drug Resistance, Multiple, Bacterial; Extensively Drug-Resistant Tubercul | 2016 |
Rapid diagnosis of MDR and XDR tuberculosis with the MeltPro TB assay in China.
Topics: Amikacin; China; Extensively Drug-Resistant Tuberculosis; Humans; Kanamycin; Microbial Sensitivity T | 2016 |
Direct electrogenerated chemiluminescence detection in high-performance liquid chromatography for determination of ofloxacin.
Topics: Chromatography, High Pressure Liquid; Electrochemistry; Electrodes; Humans; Luminescent Measurements | 2008 |
Development and validation of a HPLC method for simultaneous quantitation of gatifloxacin, sparfloxacin and moxifloxacin using levofloxacin as internal standard in human plasma: application to a clinical pharmacokinetic study.
Topics: Administration, Oral; Analytic Sample Preparation Methods; Aza Compounds; Chromatography, High Press | 2008 |
Comparison of solid-phase sorbents for the determination of fluoroquinolone antibiotics in wastewater.
Topics: Adsorption; Anti-Bacterial Agents; Cation Exchange Resins; Chromatography, High Pressure Liquid; Cip | 2008 |
Recognition mechanism of water-compatible molecularly imprinted solid-phase extraction and determination of nine quinolones in urine by high performance liquid chromatography.
Topics: Binding Sites; Chromatography, High Pressure Liquid; Computer Simulation; Humans; Hydrogen Bonding; | 2008 |
Determination of quinolone antibiotics in urine by capillary electrophoresis with chemiluminescence detection.
Topics: Anti-Infective Agents; Ciprofloxacin; Electrophoresis, Capillary; Humans; Luminescent Measurements; | 2008 |
Monitoring of Mycoplasma genitalium growth and evaluation of antibacterial activity of antibiotics tetracycline and levofloxacin using a wireless magnetoelastic sensor.
Topics: Anti-Bacterial Agents; Biosensing Techniques; Cell Proliferation; Colony Count, Microbial; Drug Eval | 2009 |
Rapid and sensitive spectrofluorimetric determination of enrofloxacin, levofloxacin and ofloxacin with 2,3,5,6-tetrachloro-p-benzoquinone.
Topics: Anti-Bacterial Agents; Chloranil; Enrofloxacin; Fluoroquinolones; Fungicides, Industrial; Levofloxac | 2009 |
Quantitative determination of levofloxacin hemihydrate in bulk and tablets by UV-spectrophotometry and first order derivative methods.
Topics: Anti-Bacterial Agents; Calibration; Levofloxacin; Ofloxacin; Quality Control; Sensitivity and Specif | 2009 |
Multicenter evaluation of Bactec MGIT 960 system for second-line drug susceptibility testing of Mycobacterium tuberculosis complex.
Topics: Amikacin; Antitubercular Agents; Capreomycin; Ethionamide; Humans; Levofloxacin; Microbial Sensitivi | 2009 |
Evaluation of a new test, genotype HelicoDR, for molecular detection of antibiotic resistance in Helicobacter pylori.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; DNA Gyrase; DNA, Bacterial; Drug Resistan | 2009 |
Thin-layer agar for detection of resistance to rifampicin, ofloxacin and kanamycin in Mycobacterium tuberculosis isolates.
Topics: Agar; Anti-Bacterial Agents; Antitubercular Agents; Bacteriological Techniques; Drug Resistance, Bac | 2009 |
Simultaneous measurement of pazufloxacin, ciprofloxacin, and levofloxacin in human serum by high-performance liquid chromatography with fluorescence detection.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Drug Stability; Fluoroquinolones; Humans; Least | 2010 |
Development and validation of a fast isocratic liquid chromatography method for the simultaneous determination of norfloxacin, lomefloxacin and ciprofloxacin in human plasma.
Topics: Anti-Infective Agents; Chromatography, Liquid; Ciprofloxacin; Drug Stability; Fluoroquinolones; Huma | 2011 |
Simultaneous determination of isoniazid, rifampicin, levofloxacin in mouse tissues and plasma by high performance liquid chromatography-tandem mass spectrometry.
Topics: Animals; Antibiotics, Antitubercular; Brain Chemistry; Chromatography, High Pressure Liquid; Female; | 2010 |
Molecularly imprinted magnetic nanoparticles as tunable stationary phase located in microfluidic channel for enantioseparation.
Topics: Capillary Electrochromatography; Hydrogen-Ion Concentration; Linear Models; Magnetite Nanoparticles; | 2010 |
A single reversed-phase UPLC method for quantification of levofloxacin in aqueous humour and pharmaceutical dosage forms.
Topics: Animals; Aqueous Humor; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Levoflo | 2010 |
Rapid detection of isoniazid, rifampin, and ofloxacin resistance in Mycobacterium tuberculosis clinical isolates using high-resolution melting analysis.
Topics: Antitubercular Agents; DNA, Bacterial; Drug Resistance, Bacterial; Genes, Bacterial; Humans; Isoniaz | 2011 |
Antimicrobial therapy for asymptomatic patients with elevated prostate-specific antigen: can the change in prostate-specific antigen reliably guide prostate biopsy decisions?
Topics: Aged; Anti-Bacterial Agents; Asymptomatic Diseases; Biopsy; Diagnostic Errors; Drug Administration S | 2011 |
Determination of ofloxacin using a highly selective photo probe based on the enhancement of the luminescence intensity of Eu3+--ofloxacin complex in pharmaceutical and serum samples.
Topics: Europium; Fluorescent Dyes; Humans; Hydrogen-Ion Concentration; Luminescence; Luminescent Measuremen | 2012 |
An LC-MS/MS method for the determination of ofloxacin in 20 μl human plasma.
Topics: Acetonitriles; Anti-Bacterial Agents; Calibration; Chromatography, Liquid; Drug Stability; Humans; M | 2012 |
Evaluation of the GenoType® MTBDRsl assay for susceptibility testing of second-line anti-tuberculosis drugs.
Topics: Antitubercular Agents; Bacterial Proteins; Capreomycin; DNA Gyrase; DNA Mutational Analysis; Drug Re | 2012 |
Integrated detection of multi- and extensively drug-resistant tuberculosis using the nitrate reductase assay.
Topics: Antitubercular Agents; Colorimetry; DNA Mutational Analysis; Drug Resistance, Multiple, Bacterial; E | 2012 |
Method validation and determinations of levofloxacin, metronidazole and sulfamethoxazole in an aqueous pharmaceutical, urine and blood plasma samples using quantitative nuclear magnetic resonance spectrometry.
Topics: Humans; Levofloxacin; Magnetic Resonance Spectroscopy; Maleates; Metronidazole; Ofloxacin; Sensitivi | 2012 |
Determination of ofloxacin in tear by HPLC-ESI-MS/MS method: comparison of ophthalmic drug release between a new mucoadhesive chitosan films and a conventional eye drop formulation in rabbit model.
Topics: Adhesiveness; Administration, Ophthalmic; Animals; Anti-Bacterial Agents; Calibration; Chemistry, Ph | 2012 |
Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory.
Topics: Amikacin; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Ethambutol; Extensively Drug- | 2012 |
Simultaneous determination of the combined drugs of ceftriaxone sodium, metronidazole, and levofloxacin in human urine by high-performance liquid chromatography.
Topics: Ceftriaxone; Chromatography, High Pressure Liquid; Ethylamines; Humans; Hydrogen-Ion Concentration; | 2012 |
Underestimation of the resistance of Mycobacterium tuberculosis to second-line drugs by the new GenoType MTBDRsl test.
Topics: Antitubercular Agents; China; DNA, Bacterial; Drug Resistance, Multiple, Bacterial; Ethambutol; Exte | 2013 |
Pharmacokinetic study of levofloxacin in rat blood and bile by microdialysis and high-performance liquid chromatography.
Topics: Animals; Anti-Infective Agents; Area Under Curve; Bile; Chromatography, High Pressure Liquid; Levofl | 2002 |
Cefepime, piperacillin/tazobactam, gentamicin, ciprofloxacin, and levofloxacin alone and in combination against Pseudomonas aeruginosa.
Topics: Cefepime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Gent | 2002 |
Pharmacodynamics of 750 mg and 500 mg doses of levofloxacin against ciprofloxacin-resistant strains of Streptococcus pneumoniae.
Topics: Ciprofloxacin; Dose-Response Relationship, Drug; Drug Resistance, Microbial; Humans; Levofloxacin; M | 2002 |
Simultaneous determination of ofloxacin, tetrahydrozoline hydrochloride, and prednisolone acetate by high-performance liquid chromatography.
Topics: Chromatography, High Pressure Liquid; Imidazoles; Ofloxacin; Prednisolone; Reference Standards; Repr | 2002 |
Antimicrobial activity of a novel des-fluoro (6) quinolone, garenoxacin (BMS-284756), compared to other quinolones, against clinical isolates from cancer patients.
Topics: Anti-Infective Agents; Ciprofloxacin; Drug Resistance, Microbial; Female; Fluoroquinolones; Gram-Neg | 2002 |
In vitro evaluation of the activity of two doses of Levofloxacin alone and in combination with other agents against Pseudomonas aeruginosa.
Topics: Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Drug Synergism; Evaluation Studies as | 2003 |
Detection of mutations in quinolone resistance-determining regions in levofloxacin- and methicillin-resistant Staphylococcus aureus: effects of the mutations on fluoroquinolone MICs.
Topics: Anti-Infective Agents; Bacterial Proteins; Base Sequence; DNA Gyrase; Drug Resistance, Multiple; Hum | 2003 |
Meropenem prevents levofloxacin-induced resistance in penicillin-resistant pneumococci and acts synergistically with levofloxacin in experimental meningitis.
Topics: Animals; Disease Models, Animal; DNA, Bacterial; Dose-Response Relationship, Drug; Drug Resistance, | 2003 |
[Cefepime (maxipime) in the treatment of severe urinary tract infection].
Topics: Adolescent; Adult; Aged; Amikacin; Anti-Bacterial Agents; Cefepime; Cephalosporins; Ciprofloxacin; D | 2003 |
Determination of levofloxacin in plasma, bronchoalveolar lavage and bone tissues by high-performance liquid chromatography with ultraviolet detection using a fully automated extraction method.
Topics: Anti-Infective Agents; Automation; Bone and Bones; Bronchoalveolar Lavage Fluid; Calibration; Chroma | 2004 |
The activity of levofloxacin and other antimicrobials against clinical isolates of Streptococcus pneumoniae collected worldwide during 1999-2002.
Topics: Anti-Bacterial Agents; Drug Resistance, Multiple, Bacterial; Global Health; Humans; Levofloxacin; Mi | 2003 |
In vitro pharmacodynamic activity of gatifloxacin, gemifloxacin, moxifloxacin and levofloxacin against Streptococcus pneumoniae containing specific mutations in DNA gyrase and topoisomerase IV.
Topics: Analysis of Variance; Aza Compounds; Culture Media; DNA Gyrase; DNA Topoisomerase IV; Drug Resistanc | 2003 |
Urinary pharmacokinetics and theoretical pharmacodynamics of intravenous levofloxacin in intensive care unit patients treated with 500 mg b.i.d. for ventilator-associated pneumonia.
Topics: Adult; Aged; Biological Availability; Critical Illness; Dose-Response Relationship, Drug; Drug Admin | 2003 |
Levofloxacin: a suitable option for the infectious disease consultant.
Topics: Anti-Bacterial Agents; Communicable Diseases; Critical Illness; Cross Infection; Humans; Intensive C | 2004 |
In vitro selection of resistance to clarithromycin in Streptococcus pneumoniae clinical isolates.
Topics: Amoxicillin; Aza Compounds; Azithromycin; Clarithromycin; Drug Resistance, Bacterial; Fluoroquinolon | 2005 |
In vitro activity of fluoroquinolones against Mycobacterium tuberculosis.
Topics: Aza Compounds; Ciprofloxacin; Drug Resistance, Bacterial; Fluoroquinolones; Gatifloxacin; Humans; Mi | 2005 |
Electrochemical determination of pharmaceuticals in spiked water samples.
Topics: Clofibric Acid; Diclofenac; Electrochemistry; Environmental Monitoring; Fresh Water; Ofloxacin; Phar | 2005 |
Flow injection spectrophotometric determination of ofloxacin in pharmaceuticals and urine.
Topics: Calibration; Ferric Compounds; Flow Injection Analysis; Humans; Ofloxacin; Pharmaceutical Preparatio | 2005 |
HPLC determination of enoxacin, ciprofloxacin, norfloxacin and ofloxacin with photoinduced fluorimetric (PIF) detection and multiemission scanning: application to urine and serum.
Topics: Chromatography, High Pressure Liquid; Ciprofloxacin; Enoxacin; Fluoroquinolones; Humans; Hydrogen-Io | 2005 |
Quantitative determination of gatifloxacin, levofloxacin, lomefloxacin and pefloxacin fluoroquinolonic antibiotics in pharmaceutical preparations by high-performance liquid chromatography.
Topics: Anti-Bacterial Agents; Calibration; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; Chr | 2006 |
In vitro and in vivo synergy of levofloxacin or amikacin both in combination with ceftazidime against clinical isolates of Pseudomonas aeruginosa.
Topics: Amikacin; Animals; Ceftazidime; Disease Models, Animal; Drug Resistance, Bacterial; Drug Synergism; | 2005 |
Quantitative determinations of levofloxacin and rifampicin in pharmaceutical and urine samples using nuclear magnetic resonance spectroscopy.
Topics: Calibration; Dimethyl Sulfoxide; Dosage Forms; Humans; Levofloxacin; Magnetic Resonance Spectroscopy | 2005 |
Determinations of fluoroquinolones and nonsteroidal anti-inflammatory drugs in urine by extractive spectrophotometry and photoinduced spectrofluorimetry using multivariate calibration.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemistry Techniques, Analytical; Ciprofloxacin; Diclofenac | 2005 |
A puzzling case of high serum creatinine in a healthy woman.
Topics: Adult; Anti-Bacterial Agents; Creatinine; Drug Administration Schedule; False Positive Reactions; Fe | 2006 |
Investigation of chromatographic conditions for the separation of ofloxacin and its degradation products.
Topics: Chromatography, High Pressure Liquid; Ofloxacin; Reproducibility of Results; Sensitivity and Specifi | 2006 |
Determination of the newer quinolones levofloxacin and moxifloxacin in plasma by high-performance liquid chromatography with fluorescence detection.
Topics: Anti-Bacterial Agents; Aza Compounds; Chromatography, High Pressure Liquid; Fluoroquinolones; Levofl | 2006 |
Flow-injection chemiluminescence determination of ofloxacin and levofloxacin in pharmaceutical preparations and biological fluids.
Topics: Anti-Infective Agents, Urinary; Cerium; Chemistry Techniques, Analytical; Chemistry, Pharmaceutical; | 2006 |
A preliminary study on the occurrence and behavior of sulfonamides, ofloxacin and chloramphenicol antimicrobials in wastewaters of two sewage treatment plants in Guangzhou, China.
Topics: Anti-Bacterial Agents; China; Chloramphenicol; Chromatography, High Pressure Liquid; Ofloxacin; Repr | 2006 |
Rapid chiral separation and impurity determination of levofloxacin by ligand-exchange chromatography.
Topics: Anti-Bacterial Agents; Chromatography, High Pressure Liquid; Chromatography, Liquid; Levofloxacin; L | 2007 |
Development of a monoclonal antibody-based broad-specificity ELISA for fluoroquinolone antibiotics in foods and molecular modeling studies of cross-reactive compounds.
Topics: Animals; Anti-Bacterial Agents; Antibodies, Monoclonal; Antibody Specificity; Ciprofloxacin; Enroflo | 2007 |
A rapid and simple high-performance liquid chromatography method for the determination of human plasma levofloxacin concentration and its application to bioequivalence studies.
Topics: Administration, Oral; Adult; Anti-Bacterial Agents; Area Under Curve; Biological Availability; Chrom | 2007 |
Determination of acid base balance and oil water partition coefficient of an atopy patch test of levofloxacin.
Topics: Acid-Base Equilibrium; Anti-Bacterial Agents; Drug Hypersensitivity; Humans; Levofloxacin; Ofloxacin | 2008 |
Validated HPTLC method for simultaneous estimation of levofloxacin hemihydrate and ornidazole in pharmaceutical dosage form.
Topics: Amebicides; Anti-Bacterial Agents; Calibration; Chromatography, Thin Layer; Dosage Forms; Levofloxac | 2007 |
Simultaneous determination of rifampicin and levofloxacin concentrations in catheter segments from a mouse model of a device-related infection by liquid chromatography/electrospray ionization tandem mass spectrometry.
Topics: Animals; Anti-Bacterial Agents; Catheters, Indwelling; Chromatography, High Pressure Liquid; Disease | 2008 |
Simultaneous determination of malondialdehyde and ofloxacin in plasma using an isocratic high-performance liquid chromatography/fluorescence detection system.
Topics: Calibration; Chromatography, High Pressure Liquid; Fluorescence; Humans; Hydrogen-Ion Concentration; | 2008 |
A reproducible, simple and sensitive HPLC assay for determination of ofloxacin in plasma and lung tissue. Application in pharmacokinetic studies.
Topics: Chromatography, High Pressure Liquid; Drug Stability; Humans; Lung; Lung Diseases, Obstructive; Oflo | 1994 |
Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial agents.
Topics: Animals; Anti-Infective Agents; Cartilage Diseases; Cartilage, Articular; Flow Cytometry; Fluorescen | 1994 |
Determination of ofloxacin in human plasma using high-performance liquid chromatography and fluorescence detection.
Topics: Acetonitriles; Anti-Infective Agents; Chemical Precipitation; Chromatography, High Pressure Liquid; | 1995 |
Accurate characterization of ofloxacin susceptibility with Enterobacteriaceae using a modified GNS F6 card and the bioMerieux Vitek System.
Topics: Anti-Infective Agents; Bacteriological Techniques; Ciprofloxacin; Enterobacteriaceae; Humans; Microb | 1996 |
Determination of ofloxacin in human aqueous humour by high-performance liquid chromatography with fluorescence detection.
Topics: Anti-Infective Agents; Aqueous Humor; Chromatography, Liquid; Humans; Ofloxacin; Sensitivity and Spe | 1997 |
Rapid stereospecific high-performance liquid chromatographic determination of levofloxacin in human plasma and urine.
Topics: Anti-Infective Agents; Chromatography, High Pressure Liquid; Drug Stability; Humans; Levofloxacin; L | 1997 |
Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacteriological Techniques; Ciprofloxaci | 1997 |
[Occurrence of Moraxella catarrhalis in patients with respiratory tract infections].
Topics: Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; Drug Resistance, Microbial; Hu | 1997 |
A reproducible, simple, and sensitive high-performance capillary electrophoresis method for simultaneous determination of capreomycin, ofloxacin and pasiniazide in urine.
Topics: Aminosalicylic Acid; Aminosalicylic Acids; Capreomycin; Electrophoresis, Capillary; Humans; Isoniazi | 1998 |
High-performance liquid chromatography separation and quantitation of ofloxacin enantiomers in rat microsomes.
Topics: Animals; Anti-Infective Agents; Calibration; Chromatography, High Pressure Liquid; Glucuronosyltrans | 1999 |
Effect of treatment on PCR positivity in multibacillary leprosy patients treated with conventional and newer drugs ofloxacin and minocycline.
Topics: Adenosine Triphosphate; Biopsy; Clofazimine; Dapsone; DNA, Bacterial; Drug Evaluation; Drug Therapy, | 1999 |
Stereoselective determination of ofloxacin and its metabolites in human urine by capillary electrophoresis using laser-induced fluorescence detection.
Topics: Administration, Oral; Anti-Infective Agents; Electrophoresis, Capillary; Fluorescence; Fluoroquinolo | 2001 |
Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination.
Topics: Aged; Aged, 80 and over; Anti-Infective Agents; Humans; Male; Mass Screening; Middle Aged; Ofloxacin | 2001 |
Ciprofloxacin- and methicillin-resistant staphylococcus aureus susceptible to moxifloxacin, levofloxacin, teicoplanin, vancomycin and linezolid.
Topics: Acetamides; Anti-Bacterial Agents; Anti-Infective Agents; Aza Compounds; Base Sequence; Ciprofloxaci | 2001 |
In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand.
Topics: Coloring Agents; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Levofloxacin; Microbia | 2001 |
Comparison of the bactericidal activities and post-antibiotic effects of the Des-F(6)-quinolone BMS-284756, levofloxacin, and ciprofloxacin against methicillin-susceptible and methicillin-resistant Staphylococcus aureus.
Topics: Anti-Infective Agents; Blood Bactericidal Activity; Ciprofloxacin; Drug Resistance, Microbial; Fluor | 2002 |
Utility of fluoroquinolones in multidrug-resistant tuberculosis (MDR-TB)--a balanced view?
Topics: Ciprofloxacin; Drug Resistance, Microbial; Female; Fluoroquinolones; Humans; Male; Microbial Sensiti | 2002 |
Separation of levofloxacin, ciprofloxacin, gatifloxacin, moxifloxacin, trovafloxacin and cinoxacin by high-performance liquid chromatography: application to levofloxacin determination in human plasma.
Topics: Anti-Infective Agents; Calibration; Chromatography, High Pressure Liquid; Humans; Hydrogen-Ion Conce | 2002 |